Terms: = Testicular cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Diagnosis
12 results:
1. Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing.
Yao X; Zhou H; Duan C; Wu X; Li B; Liu H; Zhang Y
Front Immunol; 2022; 13():1096494. PubMed ID: 36713456
[TBL] [Abstract] [Full Text] [Related]
2. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract] [Full Text] [Related]
3. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH
Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975
[TBL] [Abstract] [Full Text] [Related]
4. Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology consensus conference.
Ulbright TM; Tickoo SK; Berney DM; Srigley JR;
Am J Surg Pathol; 2014 Aug; 38(8):e50-9. PubMed ID: 24832161
[TBL] [Abstract] [Full Text] [Related]
5. testicular cancer: biology and biomarkers.
Looijenga LH; Stoop H; Biermann K
Virchows Arch; 2014 Mar; 464(3):301-13. PubMed ID: 24487784
[TBL] [Abstract] [Full Text] [Related]
6. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract] [Full Text] [Related]
7. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Emerson RE; Ulbright TM
Pathology; 2010 Jun; 42(4):344-55. PubMed ID: 20438407
[TBL] [Abstract] [Full Text] [Related]
8. testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, sox2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
[TBL] [Abstract] [Full Text] [Related]
9. [Advances in basic research on testicular germ cell tumors : clinical implications].
Looijenga LH
Urologe A; 2009 Apr; 48(4):350-8. PubMed ID: 19352605
[TBL] [Abstract] [Full Text] [Related]
10. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract] [Full Text] [Related]
11. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract] [Full Text] [Related]
12. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract] [Full Text] [Related]
